Effectiveness, safety, and retreatment outcomes in GEP-NET patients undergoing (177)Lu-based PRRT: a ten-year real-world experience.

Trinkl L, Thöne P, Dierneder J, Rumpold H

Open source

DOI
10.1186/s12885-026-16556-4
Published
2026 Jul 27
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16556-4,
  title = {Effectiveness, safety, and retreatment outcomes in GEP-NET patients undergoing (177)Lu-based PRRT: a ten-year real-world experience.},
  author = {Trinkl L and Thöne P and Dierneder J and Rumpold H},
  year = {2026},
  journal = {BMC cancer},
  doi = {10.1186/s12885-026-16556-4},
  url = {https://doi.org/10.1186/s12885-026-16556-4}
}

RIS

TY  - JOUR
TI  - Effectiveness, safety, and retreatment outcomes in GEP-NET patients undergoing (177)Lu-based PRRT: a ten-year real-world experience.
AU  - Trinkl L
AU  - Thöne P
AU  - Dierneder J
AU  - Rumpold H
PY  - 2026
JO  - BMC cancer
DO  - 10.1186/s12885-026-16556-4
UR  - https://doi.org/10.1186/s12885-026-16556-4
ER  - 

APA

L, T., P, T., J, D., & H, R. (2026). Effectiveness, safety, and retreatment outcomes in GEP-NET patients undergoing (177)Lu-based PRRT: a ten-year real-world experience.. BMC cancer. https://doi.org/10.1186/s12885-026-16556-4

Source records